Futerman AH - Search Results

1

X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease.

Dvir H, Harel M, McCarthy AA, Toker L, Silman I, Futerman AH, Sussman JL. Dvir H, et al. Among authors: futerman ah. EMBO Rep. 2003 Jul;4(7):704-9. doi: 10.1038/sj.embor.embor873. EMBO Rep. 2003. PMID: 12792654 Free PMC article.

2

Purification and crystallization of a dimeric form of acetylcholinesterase from Torpedo californica subsequent to solubilization with phosphatidylinositol-specific phospholipase C.

Sussman JL, Harel M, Frolow F, Varon L, Toker L, Futerman AH, Silman I. Sussman JL, et al. Among authors: futerman ah. J Mol Biol. 1988 Oct 5;203(3):821-3. doi: 10.1016/0022-2836(88)90213-6. J Mol Biol. 1988. PMID: 2850366

3

Modes of attachment of acetylcholinesterase to the surface membrane.

Silman I, Futerman AH. Silman I, et al. Among authors: futerman ah. Eur J Biochem. 1987 Dec 30;170(1-2):11-22. doi: 10.1111/j.1432-1033.1987.tb13662.x. Eur J Biochem. 1987. PMID: 3319614 Free article. Review.

4

A membrane-associated dimer of acetylcholinesterase from Xenopus skeletal muscle is solubilized by phosphatidylinositol-specific phospholipase C.

Inestrosa NC, Fuentes ME, Anglister L, Futerman AH, Silman I. Inestrosa NC, et al. Among authors: futerman ah. Neurosci Lett. 1988 Jul 19;90(1-2):186-90. doi: 10.1016/0304-3940(88)90809-9. Neurosci Lett. 1988. PMID: 3412641

5

Posttranslational modification as a means of anchoring acetylcholinesterase to the cell surface.

Silman I, Futerman AH. Silman I, et al. Among authors: futerman ah. Biopolymers. 1987;26 Suppl:S241-53. doi: 10.1002/bip.360260021. Biopolymers. 1987. PMID: 3555636 No abstract available.

6

Analysis of glucocerebrosidase activity using N-(1-[14C]hexanoyl)-D-erythroglucosylsphingosine demonstrates a correlation between levels of residual enzyme activity and the type of Gaucher disease.

Meivar-Levy I, Horowitz M, Futerman AH. Meivar-Levy I, et al. Among authors: futerman ah. Biochem J. 1994 Oct 15;303 ( Pt 2)(Pt 2):377-82. doi: 10.1042/bj3030377. Biochem J. 1994. PMID: 7980395 Free PMC article.

7

Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide.

Bodennec J, Pelled D, Riebeling C, Trajkovic S, Futerman AH. Bodennec J, et al. Among authors: futerman ah. FASEB J. 2002 Nov;16(13):1814-6. doi: 10.1096/fj.02-0149fje. Epub 2002 Sep 5. FASEB J. 2002. PMID: 12223447

8

New directions in the treatment of Gaucher disease.

Futerman AH, Sussman JL, Horowitz M, Silman I, Zimran A. Futerman AH, et al. Trends Pharmacol Sci. 2004 Mar;25(3):147-51. doi: 10.1016/j.tips.2004.01.004. Trends Pharmacol Sci. 2004. PMID: 15019270 Review. No abstract available.

9

Phosphatidylcholine metabolism is altered in a monocyte-derived macrophage model of Gaucher disease but not in lymphocytes.

Trajkovic-Bodennec S, Bodennec J, Futerman AH. Trajkovic-Bodennec S, et al. Among authors: futerman ah. Blood Cells Mol Dis. 2004 Jul-Aug;33(1):77-82. doi: 10.1016/j.bcmd.2004.03.001. Blood Cells Mol Dis. 2004. PMID: 15223015

10

The complex life of simple sphingolipids.

Futerman AH, Hannun YA. Futerman AH, et al. EMBO Rep. 2004 Aug;5(8):777-82. doi: 10.1038/sj.embor.7400208. EMBO Rep. 2004. PMID: 15289826 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

276 results

Search Page

Filters